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Abstract
Background: Diabetes, a global cause of mortality in developing countries is a chronic disorder affecting the
metabolism of macromolecules and has been attributed to the defective production and action of insulin
characterized by persistent hyperglycemic properties. This global disorder harms organs of the body such as the
liver, kidney and spleen. Medicinal plants such as Hunteria umbellate have been shown to possess hypoglycemic,
antioxidative and anti-diabetic properties owing to the high concentration of active phytochemical constituents like
flavonoids and alkaloids.
The present study seeks to evaluate the hypoglycemic activities of ethanolic seed extract of Hunteria umbellate on
streptozotocin-induced diabetes rats.
Methods: Thirty (30) female experimental rats were randomly divided into five groups with six rats per group and
were administered streptozotocin (STZ) and Hunteria umbellate as follows. Group 1 served as control and was given
only distilled water, group 2 rats were administered 60 mg/kg STZ; Group 3 was administered 60 mg/kg STZ and
100 mg/kg metformin; group 4 rats were administered 60 mg/kg STZ and 800 mg/kg Hunteria umbellate, group 5
rats 60 mg/kg STZ and 400 mg/kg Hunteria umbellate. The fasting blood glucose level of each rat was measured
before sacrifice. Rats were then sacrificed 24 h after the last dose of treatment.
Results: The results showed that Hunteria umbellate significantly reversed STZ-induced increase in fasting blood
glucose and increase in body and organs weight of rats. Hunteria umbellate significantly reversed STZ-induced
decrease in antioxidant enzyme in liver, kidney and spleen of rats. Hunteria umbellate significantly reversed STZ-
induced increase in oxidative stress markers in liver, kidney and spleen of rats.
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Conclusion: Collectively, our results provide convincing information that inhibition of oxidative stress and
regulation of blood glucose level are major mechanisms through which Hunteria umbellate protects against
streptozotocin-induced diabketes rats.
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Background
According to the International Diabetes Federation
(IDF), approximately 13.6 million people in Africa have
diabetes. Sub-saharan Africa is estimated to have a dia-
betes incidence burden of over 7 million people this esti-
mate is expected to double and exceed 15 million by
2025. The prevalence of diabetes varies by region based
on the level of development and civilization, especially in
Africa. In the rural or less developed areas the preva-
lence is about 1 % which sharply contrast with about 7 %
prevalence in developing areas and about 8–13 % in
more developed areas in sub-Saharan Africa [1].
Perhaps, one of the oldest disorders known to human-
ity is diabetes mellitus. It is a chronic metabolic disorder
emanating either from insulin deficiency (Insulin inad-
equacy brings about Type 1 Diabetes Mellitus - T1DM)
or insensitivity of insulin (Type 2 Diabetes Mellitus -
T2DM). T2DM arises from a couple of factors and may
arise as a synergy between hereditary, ecological and so-
cial risk factors. It is often associated with features such
as hyperglycemia, insulin resistance and deficiency of in-
sulin [5].
Normally, individuals with diabetes have a risk of de-
veloping a progressive illness, for example, visual impair-
ment, renal infection, coronary disease, cerebrovascular
and peripheral vascular diseases [2]. T2DM, if uncon-
trolled and unmanaged, may result into short and long
term complexities which are perhaps lethal. There are
various complications related to T2DM which evolves
around diabetic nephropathy [3], diabetic neuropathy
[4], diabetic retinopathy [5], diabetic ketoacidosis [6],
stroke, liver injury [7], fatty liver disease and a lot more.
Elevated liver enzymes, fatty liver disease, cirrhosis, he-
patocellular carcinoma and acute liver failure are exam-
ples of liver associated disorders found in diabetes [8].
Chronically elevated insulin level, as well as relative in-
sulin resistance, cause a cascade of reactions that lead to
an increase in lipogenesis and associated fatty changes.
Excess amount of free fatty acid is known to be hepato-
toxic leading to disruption of the cell membrane, mito-
chondrial dysfunction, oxidative damage and increase in
proinflammatory cytokine – tissue Necrotic Factor [7].
The kidney on the other hand is an extremely complex
organ with versatile functions in the body, including, but
not limited to, removal of waste, ion and water balance,
blood pressure maintenance, regulation of glucose level
and erythropoietin generation or vitamin D activation
[9]. Under diabetic conditions, many of these processes
are disturbed via a combination of hemodynamic and
metabolic changes; hyperglycemia also activates a series
of changes leading to glomerular and tubular dysfunc-
tion accelerating glomerular cell death [9].
Diabetes significantly diminishes immune response cap-
acity, it causes a suppression of immune cell function, re-
duction in the size of organs of the immune system such
as the spleen [10]. Hossam et al. (2015) reported the detri-
mental pathological effects of diabetes on an important
organ of the immune system which is the spleen and the
treatment effect of phytochemicals [10].
It has been reported that over 64 % of the world popu-
lation depends on medicinal plants for their primary
health care [11]. Across Africa, there is little or no access
to modern medicine and a lot of citizens depend on in-
digenous medicine or health care [12]. With this in-
crease in the incidence of diabetic patients in the world,
there is also a need to discover and validate the effective-
ness of more therapeutic agents in the management of
diabetes mellitus.
Herbs, spices and indigenous plants have been utilized
for treating diabetes in Egypt, India and China for many
years. Such plants include onion, garlic, neem, etc. Onion
has a hypoglycemic impact in fasting depancreatized rats.
Therapeutic plants are modest, effectively accessible and
have no deleterious effects, and accordingly may be con-
sidered as another option in treating diabetes.
The extracts from various parts of Hunteria umbellata
are of great value in the local management of various ail-
ments and diseases. Among the Yoruba herbalists, pow-
dered dry seeds of Hunteria umbellata are presumed for
the treatment of fever, torment, stomach colic and incon-
veniences, diabetes mellitus and obesity. In diabetes melli-
tus local treatment, a normal of 2–3 teaspoonful’s (10–
15 g) of powdered dry seed immersed a glass of high temp
water for 20–30 min is prescribed for a grown-up to be
taken orally every day [13]. Extracts from Hunteria umbel-
lata have been shown to have antidiabetic, antioxidative
and erection stimulating properties [14–16]. It also has
aphrodiac properties via the modualtion of arginase and
nitric oxide activities [17], Its alkaloid fraction has been
shown be cardioprotective and hyperlipidemic [18].
This study aims to evaluate the hypoglycemic activities
of the ethanolic seed extract of Hunteria umbellata and
its effect on the oxidative markers in organs of albino
rats induced with streptozotocin-induced diabetes.
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Materials and methods
Chemicals and reagents
Streptozotocin (STZ), Glucose-D, potassium dihydrogen
phosphate (KH2PO4), dipotassium hydrogen phosphate
(K2HPO4), 10 % Trichloroacetic acid (TCA), Ellman’s re-
agent, 5, 5-dithiobisnitro benzoic acid (DTNB), sodium
nitrate, Glutathione powder, 1-chloro-2,4-dinitrobenzene
(CDNB), Ethanol, hydrogen peroxide were all obtained
from SIGMA, USA and Clous clone Int’l Wuhan, China.
Plant collection
Seeds of Hunteria umbellata plant were collected from
Ota market, Ogun State, Nigeria in August 2020. Botan-
ical identification and authentication were done by Dr
Popoola, Covenant University, Ota, Ogun State, Nigeria.
The seeds were completely dried under room
temperature for 4 weeks protected from direct heat or
sunlight. After drying, the seeds were de-coated from
their light brown thin coatings.
Plant extraction
Upon collected and identification of Hunteria umbellata
seeds, 215 g of the dry seeds were weighed and then
grounded to a white-to-light brown fine powder using a
domestic blender. Consequent upon grinding of the
seeds, 206 g of the finely powdered sample was soaked
in 1833 ml of ethanol and made to total volume. It was
left to stand for 72 h in an air-tight container and stirred
at intervals. After 72 h, the mixture was vigorously
shaken and filtered using a piece of clean muslin cloth.
The filtrate was kept in an air-tight container. The resi-
due was re-soaked in ethanol and left to stand for an-
other 72 h with stirring at intervals. The mixture was
filtered and the filtrate was added to the first and the
crude extract was obtained using the rotary evaporator
with a percentage yield of 89 %.
Experimental animals
Thirty (30) female white albino Wistar rats (4–8 weeks
old), weighing 150-200 g were obtained in the central
animal house, Covenant University, Ota. Upon collec-
tion, all animals were fed a standard feed and water ad
libitum initially for two weeks for acclimatization before
the commencement of any form of any treatment. Ethics
protocols as laid down by the animal ethics committee
of the Department of Biological Sciences, Covenant Uni-
versity, Ota, Ogun State, Nigeria (PCU/ACUREC/018).
Diabetes induction
Following an overnight fast and except for animals in
the negative control group, all animals were given a sin-
gle intraperitoneal injection of 60 mg/kg STZ freshly dis-
solved in citrate buffer pH 4.5 targeted at inducing
diabetes. A status of hyperglycaemia was ascertained
72 h after the injection by estimating the blood glucose
level with an Accu-check sensor comfort glucometer.
Only the rats with fasting blood glucose levels ≥ 250 mg/
dl were considered diabetic.
Experimental design
Diabetic rats were weighed and distributed into 5 groups
each consisting of 6 rats as shown in the table
below (Table 1).
The animals were dosed according to their body
weight. The fasting blood glucose of each animal was
also checked by measuring the tail vein blood glucose
level with an Accu-check sensor comfort glucometer.
Oral Glucose Tolerance Test (OGTT)
Two types of Oral glucose tolerance test were per-
formed: Diabetic OGTT (on diabetic animals) and Nor-
moretic Oral glucose tolerance test (on non-diabetic
animals).
The animals fasted for 12 h before the day of OGTT.
The fasting glycaemia was measured and defined as
zero-time. After this procedure, the animals received
their treatment orally and after 30 min all the groups re-
ceived an oral load of glucose (2.0 kg/bw). The blood
glucose levels were then measured 30, 60, 120 and
150 min after administration of glucose as shown in
Tables 2 and 3.
Reduced glutathione determination
Reduced glutathione on reaction with DTNB (5,5’-
dithiobis nitro benzoic acid) forms a lightly coloured
product that absorbs light maximally at about 412 nm.
The reduced glutathione (GSH) content of liver tissue as
non-protein sulphydryls was estimated according to the
method described by Sedlak and Lindsay, [19].
Table 1 Experimental design describing the groupings and dosage
GROUP LABEL DOSAGE No OF ANIMALS
1. Normal control Distilled water 6
2. Positive control 60 mg/kg STZ 6
3. Positive control 60 mg/kg STZ + Metformin (100 mg/kg) 6
4. Plant extract 60 mg/kg STZ + H. umbellata (400 mg/kg) 6
5. Plant extract 60 mg/kg STZ + H. umbellata (800 mg/kg) 6
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Glutathione- S- transferase activity determination
Glutathione –S- transferase an enzyme that utilizes
glutathione as a cofactor in its antioxidative activity was
determined by the method according to Habig et al.,
[20]. This enzyme demonstrates a relatively high activity
with 1-Chloro − 2,4-dinitrobenzene (CDNB) as the sec-
ond substrate. Consequently, the conventional assay for
glutathione–s-transferase activity utilizes 1-Chloro-2,4-
dinitrobenzene as substrate. When this substrate is con-
jugated with reduced glutathione (GSH), its absorption
maximum shifts to a longer wavelength. The absorption
increase at the new wavelength of 340 nm which pro-
vides a direct measurement of the enzymatic reaction.
Catalase activity determination
The UV absorption of hydrogen peroxide can be mea-
sured at 240 nm, whose absorbance decreases when de-
graded by the enzyme catalase. From the decrease in
absorbance, enzyme activity can be calculated. Serum
catalase activity was determined according to the method
of Beers and Sizer as described by Usoh et al., [21].
Lipid peroxidation
Thiobarbituric acid reactive substances is an index of lipid
peroxidation. This was determined by measuring thiobar-
bituric acid reactive substances (TBARS) present the hom-
ogenate using the method of Beuge and Aust, [22].
Peroxidase determination
In the presence of the hydrogen donor pyrogallol, perox-
idase converts hydrogen peroxide to water and oxygen.
The oxidation of pyrogallol to a coloured product called
purpurogallin can be followed spectrophotometrically
at430nm. The method proposed by Reddy et al. [23] was
adopted for assaying the activity of peroxidase.
Statistical analysis
All data are expressed as mean and Standard Error of
Means (S.E.M.). One-way analysis of variance (ANOVA)
was performed using GraphPad prism 6.0. Multiple
comparison was done using Tukey’s multiple compari-
son test (p < 0.05).
Results
Fasting blood glucose levels of experimental animals
were significantly reduced when compared to negative
control as shown in Table 4 (p < 0.05).
Metformin, H.U 800 mg and H.U 400 mg are groups
treated with 100 mg/kg metformin, 800 mg/kg H.
umbellata and 400 mg/kg H. umbellata respectively.
The positive and negative controls are untreated diabetic
and untreated non-diabetic groups respectively.
Metformin, H.U 800 mg and H.U 400 mg are groups
treated with 100 mg/kg metformin, 800 mg/kg H.
umbellata and 400 mg/kg H. umbellata respectively.
The negative and normal controls are untreated diabetic
and untreated non-diabetic groups respectively.
Metformin, H. umbellata 800 mg and H. umbellata
400 mg are groups treated with 100 mg/kg metformin,
800 mg/kg H. umbellata and 400 mg/kg H. umbellata
respectively. The positive and negative controls are un-
treated diabetic and untreated non-diabetic groups
respectively.
Metformin, H. umbellata 800 mg and H. umbellata
400 mg are groups treated with 100 mg/kg metformin,
800 mg/kg H. umbellata and 400 mg/kg H. umbellata
respectively. The positive and negative controls are un-
treated diabetic and untreated non-diabetic groups
respectively.
We observed that in the liver of STZ induced diabetic
rats, there was a significant decline in glutathione,
glutathione-S- transferase, and peroxidase levels when
Table 2 Effect of H. umbellata on oral glucose tolerance test in diabetic rats
GROUPS Zero time 30 min 60 min 120 min 150 min
CONTROL 82.83 ± 6.60 b 151.83 ± 28.20 b 157.16 ± 12.05 b 116.16 ± 7.52 b 89.33 ± 6.40 b
60 mg/kg STZ 421.00 ± 42.43*a 495.40 ± 64.06*a 466.00 ± 76.24*a 423.40 ± 85.60*a 362.40 ± 78.97*a
60 mg/kg STZ +METFORMIN 188.20 ± 64.38b 159.20 ± 45.35b 94.60 ± 26.78b 74.60 ± 12.96 b 70.80 ± 11.55 b
60 mg/kg STZ + H.U. 400 mg 368.33 ± 95.86* 450.33 ± 74.43*a 393.00 ± 80.10*a 330.00 ± 66.05*a 247.16 ± 74.13*a
60 mg/kg STZ + H.U. 800 mg 230.66 ± 90.93 474.00 ± 35.23*a 450.66 ± 52.34*a 408.66 ± 51.77*a 353.00 ± 67.81*a
Superscripts * a b represent values that are significantly (p < 0.05) different from negative control, metformin treated group and positive control respectively
Table 3 Effect of H. umbellata on oral glucose tolerance test in non-diabetic rats
GROUPS ZERO 30 min 60 min 120 min
60 mg/kg STZ +METFORMIN 75.33 ± 2.96 105.67 ± 25.67 95.33 ± 12.33 64.00 ± 8.14
60 mg/kg STZ + H.U 102.00 ± 4.16*a 131.00 ± 20.93 110.67 ± 10.87 86.67 ± 7.83*
NORMAL CONTROL 82.83 ± 6.61 151.83 ± 28.20 157.11 ± 12.05 116.17 ± 7.52
Superscripts * a b represent values that are significantly (p < 0.05) different from negative control, metformin treated group and positive control respectively
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compared to the negative control. However, treament
with metformin and graded doses of H.umbellata led to
significant amelioration when compared to STZ- only
treatment group as shown in Fig. 1. Also, adminstration
of STZ lead to significant elevation in lipid peroxidation
as compared negative control group. Interestingly,
meformin and graded doeses of H.umbellata lead to sig-
nificant amelioration when compared to STZ-only treat-
ment group.
Results from this study shows that in the kidney of
STZ induced diabetic rats, there was a significant de-
cline in glutathione, glutathione-S- transferase, and
peroxidase levels when compared to the negative con-
trol. However, treament with metformin and graded
doses of H.umbellata led to significant amelioration
when compared to STZ- only treatment group as
shown in Fig. 2. Also, adminstration of STZ lead to
significant elevation in lipid peroxidation as compared
negative control group. Interestingly, meformin and
graded doeses of H.umbellata lead to significant
amelioration when compared to STZ-only treatment
group.
Results from this study shows that in the spleen of
STZ induced diabetic rats, there was a significant decline
in glutathione, glutathione-S- transferase, and peroxidase
levels when compared to the negative control. However,
treament with metformin and graded doses of H.umbel-
lata led to significant amelioration when compared to
STZ-only treatment group as shown in Fig. 3. Also,
adminstration of STZ lead to significant elevation in
lipid peroxidation as compared negative control group.
Interestingly, meformin and graded doeses of H.umbel-
lata lead to significant amelioration when compared to
STZ-only treatment group.
Discussion
Glucose homeostasis is constrained by endocrine pan-
creatic cells, and any pancreatic unsettling influence can
bring about diabetes. Hyperglycemia enhances the pro-
duction of reactive oxygen species, leading to oxidative
stress which is involved in the damage and failure of dif-
ferent organs such as the kidney, spleen and liver. To
combat the damage induced by the chronic hypergly-
cemia associated with diabetes, studies have shown that
therapeutic plants with high quantities of flavonoids and
alkaloids usually possess hypoglycemic and antidiabetic
effects. One of such therapeutic plants is the H. umbel-
late. This study, therefore, examined the protective effect
of ethanol extract of H. umbellate against hyperglycemia
associated with diabetes induced by streptozotocin.
Table 4 Percentage reduction in fasting blood glucose levels
GROUPS % REDUCTION
NORMAL CONTROL 7.96
60 mg/kg STZ 15.79
60 mg/kg STZ +METFORMIN 81.73*
60 mg/kg STZ + H.U. 400 mg 79.18*
60 mg/kg STZ + H.U. 800 mg 82.44*
Superscripts * a b represents values that are significantly different from
negative control, metformin group and positive control respectively (p < 0.05)
Fig. 1 Effect on oxidative markers in the liver. Superscripts * a b represent values that are significantly (p < 0.05) different from negative control,
metformin treated group and positive control respectively. GSH, TBARS, PER, GST, STZ and HU represents reduced glutathione, thiobarbituric acid
reactive substances, peroxidase, glutathione-s-transferase, streptozotocin and Hunteria umbellata respectively
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The continuous administration of streptozotocin for 3
weeks brought about critical diminishing of blood glu-
cose levels in the negative control group, in the co-
treated group, the blood glucose level was restored when
compared with the untreated diabetic rats (Table 4). The
most potent hyperglycemic power of H. umbellata
dependent on improving FBG levels was observed at a
dose of 800 mg/kg which was similar to metformin
Fig. 2 Effect on oxidative markers in the kidney. Superscripts * a b represent values that are significantly (p < 0.05) different from negative control,
metformin treated group and positive control respectively. GSH, TBARS, PER, GST, STZ and HU represents reduced glutathione, thiobarbituric acid
reactive substances, peroxidase, glutathione-s-transferase, streptozotocin and Hunteria umbellata respectively
Fig. 3 Oxidative marker levels in the spleen. Superscripts * a b represent values that are significantly (p < 0.05) different from negative control,
metformin treated group and positive control respectively. GSH, TBARS, PER, GST, STZ and HU represents reduced glutathione, thiobarbituric acid
reactive substances, peroxidase, glutathione-s-transferase, streptozotocin and Hunteria umbellata respectively
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(standard medication). The glucose reducing impacts of
H. umbellata could be attributed to the presence of a
high amount of flavonoids, terpenes, cardiovascular gly-
cosides, saponins, etc. [24].
Streptozotocin-induced diabetes is characterized by
extreme loss of body weight. This decrease in weight
might be brought about by catabolic responses prompt-
ing degradation of primary proteins because of diabetes.
Primary proteins are known to add to body weight. In
this study, following STZ administration, the blood glu-
cose levels of rats significantly increased; this is accom-
panied by huge diminishing body weight. Be that as it
may, treatment with H. umbellata concentrate and met-
formin restored the bodyweight step by step (Fig. 4).
The weight gains in diabetic rats is possibly because of
the capacity of the treatments to diminish hypergly-
caemia [25]. This is in accordance with the report from
Longe and Momoh, [24] that treatment with methanolic
extract of H. umbellata appreciably increased the weight
of diabetic animals after 14 days.
Contrary to the overall decrease in body weight ob-
served in STZ- induced diabetic rats, a significant in-
crease in the relative weights of the liver and kidney
were observed in comparison to the normal rats and sig-
nificant decreases in the weight of the spleen compared
to the normal control (Table 5). This could be an index
of organ impairment [26].
Oral glucose tolerance test gauges the capacity of the
body to use the main source of energy which is glucose.
H. umbellata diminished blood glucose levels in both
normal and STZ-initiated diabetic rodents. In this man-
ner, the concentrate upgraded glucose use and improves
resistance in glucose loaded rodents.
Diabetes induces oxidative stress through the overpro-
duction of reactive oxygen species [27]. Antioxidants
combat or counter the effect of oxidative stress by neu-
tralizing these reactive oxygen species. Peroxidase is an
inducible catalyst which expressed uniquely under con-
ditions that permit its gene expression. It catalyzes a re-
sponse of the structure: ROOR’ + electron donor (2 e
−) + 2 H+ → ROH + R’OH. The ideal substrate is hydro-
gen peroxide, and it is initiated by the presence of
hydrogen peroxide. An increase in the activities of per-
oxidase in the liver and kidney of H. umbellata–treated
rats indicates increased levels of hydrogen peroxide, and
its activity could be linked to efficient hydrogen peroxide
scavenging power of H. umbellata. An increase in the
activity of GST in kidneys of H. umbellata–treated rats
compared to the untreated diabetic rats, demonstrates
the ability of the seed extract to combat free radicals.
These increases in H. umbellata- treated rats are com-
parable to that of metformin-treated rats, this suggests
that metformin has a greater ability to combat free
radicals.
Lipid peroxides are the secondary products of oxida-
tive stress and develop because of ROS generated during
lipid peroxidation in diabetes. Raised amounts of lipid
peroxides in the liver tissue uncover a serious level of
lipid peroxidation which is viewed as a pointer of hep-
atocyte damage. They may likewise respond with transi-
tion metals like iron or copper to frame stable
aldehydes, for example, malondialdehyde (MDA), that
harm cell membranes [28]. An increase in lipid peroxi-
dation suggests a decline in defence mechanisms of en-
zymatic and non-enzymatic antioxidants. The reduction
in the thiobarbituric acid reactive substances (TBARS)
concentrations in the kidneys and liver of rats treated with
H. umbellata suggests an increase in the activity of antioxi-
dant enzymes [29]. Additionally, the presence of alkaloids
and flavonoids in H. umbellata could represent its defensive
consequences for the liver and kidney, since these phyto-
chemicals have been accounted for to give insurance on the
kidneys and liver through avoidance of tissue lipid peroxi-
dation which clarifies their cell reinforcement and free rad-
ical scavenging activities [30, 31].
GSH is a significant non-protein thiol in living crea-
tures that assumes a focal role in planning the body’s
cell antioxidant guard measure [32]. It is associated with
cell protection against xenobiotic and normally reactive
species. A few reports acclaim that the GSH framework
can be overpowered if ROS are generated in overabun-
dance. In Table 7, high convergence of GSH and were
seen in the kidney in H. umbellata-treated rodents in
Fig. 4 Weight changes throughout treatment
Table 5 Relative organ weight
GROUPS LIVER KIDNEY SPLEEN
NORMAL CONTROL 3.53 ± 0.09a 0.72 ± 0.04ab 0.54 ± 0.05a
60 mg/kg STZ 3.61 ± 0.17a 0.90 ± 0.05 0.38 ± 0.04
60 mg/kg STZ +METFORMIN 4.51 ± 0.29b* 0.93 ± 0.03 0.30 ± 0.06
60 mg/kg STZ + H.U. (800 mg) 4.76 ± 0.06b* 0.83 ± 0.04 0.44 ± 0.06
60 mg/kg STZ + H.U. (400 mg) 4.65 ± 0.12b* 0.84 ± 0.03 0.47 ± 0.86
Superscripts * a b represent values that are significantly (p < 0.05) different
from negative control, metformin treated group and positive
control respectively
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examination with the untreated diabetic rodents. This
demonstrates that the plant has free radical scavenging
capability.
Conclusions
Overall, based on the above results, the antidiabetic ac-
tivity of H. umbellata at 800 mg/kg is comparable to
that of metformin and the increase in the activity of
GST, GSH and peroxidase shows that the seed extract of
H. umbellata owing to its strong antioxidant potential
can reduce the oxidative stress generated in diabetes,
thereby protecting against diabetes-induced oxidative
damage.
Therefore, it can be concluded that H. umbellata pro-
tects against streptozotocin-induced diabetes via regula-
tion of blood glucose, inhibition of oxidative stress and
enhancement of antioxidant enzymes in the liver, spleen
and kidney.
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